A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.
A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.